In the present study, the antibiofilm, antipathogenic and anticarotenogenic potential of L-ascorbyl 2,6-dipalmitate (ADP) against methicillin-resistant Staphylococcus aureus (MRSA) has been evaluated. 
Introduction
Biolm formation by bacterial pathogens on/within indwelling medical devices and implants poses a serious threat in clinical settings. 1 According to reports by the Centre for Disease Control 2 (CDC) and National Institute of Health 3 (NIH), 65 to 80% of bacterial infections are associated with biolm formation. Biolms are a monospecies/multi-species microbial assemblage encased in self-secreted extracellular polymeric substances (EPS; including proteins, polysaccharides and extracellular DNA) formed on biotic and abiotic surfaces. 4 Most bacterial pathogens have an innate ability to form a highly protective biolm to escape from host immune responses and antimicrobial agents. 5 Formation of a biolm provides multilevel protection to microbes against antibiotics, due to the slower growth rate and altered metabolism of microbes in biolms, the production of dormant persister cells, and EPSmediated blockage of the penetration of antimicrobial agents.
6 When compared to planktonic cells, bacterial cells that reside in a biolm matrix are highly resistant to antibiotics. 7 Hence, biolm formation by bacterial pathogens has been considered as a major cause of therapeutic failure and antimicrobial resistance development. 
18
Methanolic extracts of marine alga Padina boergesenii and the corresponding L-ascorbyl 2,6-dipalmitate (ADP)-rich fractions have been previously reported to have the ability to inhibit biolm formation by MRSA. 19 ADP is a fatty ester derivative of ascorbic acid and it has been used as an antioxidant and skin whitening agent in cosmetic preparations. 20 In addition, based on a safety evaluation, a Cosmetic Ingredient Review (CIR) expert panel has conrmed that ADP is a generally regarded as safe (GRAS) ingredient.
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Feeding F344 rats an ADPsupplemented (5%) diet for 32 weeks does not have any negative impact. 22 Hence the possibility of ADP toxicity has been ruled out. The effect of ADP treatment on biolm formation by MRSA was assessed in the current investigation using standard qualitative and quantitative assays. Furthermore, the action of ADP on virulence factors such as slime, lipase, autolysin, and hemolysin was also examined. In addition, the effects of cotreatment/combination of ADP with certain antibiotics on the growth of MRSA were also analysed. Cholesterol-lowering drugs have been shown to inhibit staphyloxanthin pigment production by S. aureus. 23 The nematode Caenorhabditis elegans is recognised as a model system to study fat synthesis, storage and metabolism. 24 Comparative genomic and functional analysis of the genes involved in lipid metabolism in C. elegans revealed that 70% of the genes have human orthologs. 25 Hence, C. elegans has been successfully used as an in vivo model for screening anti-obesity/lipid-lowering drugs. 26 ADP exhibited potent inhibitory activity against staphyloxanthin production by MRSA, and hence the present study was further extended to evaluate the anti-obesity potential of ADP through analysing the effect of ADP on triacylglyceride accumulation in C. elegans fed with a high fat diet (i.e. standard nematode growth medium (NGM) supplemented with 25 mM cholesterol).
Materials and methods

Ethics statement
Healthy human blood and plasma were used in the present study to analyse the effect of ADP treatment on the hemolysin production, blood survival and biolm formation of Staphylococcus aureus MRSA [ATCC 33591]. The experimental procedures and the use of healthy human blood was evaluated and approved by the Institutional Ethical Committee, Alagappa University, Karaikudi (IEC Ref No: IEC/AU/2016/1/4). The blood samples from healthy individuals were collected by trained personnel as per the standard guidelines and "written informed consent" was obtained from all subjects. All experiments were performed in compliance with the relevant laws and institutional guidelines (Ethical Guidelines for Biomedical Research on Human Participants, Indian Council of Medical Research, India).
Bacterial strains and culture conditions
Staphylococcus aureus MRSA [ATCC 33591] was grown and maintained on tryptic soy agar/broth (TSA/TSB) at 37 C and stored at 4 C. For biolm formation, TSB containing 0.25% glucose (TSBG) was used. Escherichia coli OP50, used as a Caenorhabditis elegans food source, was obtained from CGC and maintained on LB agar/broth at 37 C and stored at 4 C.
2.3. Antibiolm assay, and light and confocal laser scanning microscopic observation of biolms ADP (CAS No: 4218-81-9) was procured from TCI Chemicals (India) Pvt. Ltd and dissolved in acetone to form a 10 mg mL
À1
stock. The antibiolm activity of ADP was assessed using a 24-well micro titre plate (MTP) assay. 27 Briey, each well containing 1 mL of TSBG was inoculated with an overnight culture of MRSA to an initial optical density (OD) of 0.05 at 600 nm, supplemented with 10 to 100 mg mL À1 of ADP with the concentration increasing in 10 mg mL À1 increments, and incubated for 24 h at measured at 570 nm using a multi-label reader (Spectramax M3, USA). In addition, the effect of ADP treatment on the initial attachment 28 and biolm formation of MRSA on plasma-coated surfaces was also analysed. 29 Biolms formed in the presence and absence of ADP were visualised under light and confocal laser scanning microscopes. 30 Detailed procedures are presented in the ESI. †
Ring biolm inhibition assay
The effect of ADP on ring biolm formation at the air-liquid interface was assessed by growing MRSA in glass tubes containing 2 mL of TSB supplemented with or without 20 to 100 mg mL À1 of ADP (with the concentration of ADP increasing in 20 mg mL À1 increments) for 48 h at 37 C with shaking at 160 rpm.
Aer incubation, the tubes were visually observed and photographed.
2.5. Effect of ADP on autoaggregation, slime production, colony morphology and virulence factor production of MRSA Autoaggregation of control and ADP-treated MRSA cells was assessed spectrometrically. 31 The effect of ADP on slime synthesis 32 and colony morphology was assessed on Congo red agar and tryptic soy agar, respectively, and the agars were visually observed and photographed. Cell-free culture supernatant (CFCS) from MRSA grown in the presence or absence of 10 to 100 mg mL À1 of ADP (with the concentration of ADP increasing in 10 mg mL À1 increments) was collected by centrifugation and used for hemolysin 33 and lipase assays. 34 The cell pellets were used for analysis of autolysin production, 35 and extraction and quantication of staphyloxanthin pigment.
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Detailed procedures are presented in the ESI. † 2.6. Effect of ADP on staphyloxanthin inhibition and survival of MRSA in whole blood, and in the presence of H 2 O 2 and singlet oxygen (methylene blue) MRSA control and ADP-treated cells were incubated in freshly drawn blood (heparinized), 36 PBS containing 1 mM hydrogen peroxide (H 2 O 2 ) 36 and 10 mg mL À1 of methylene blue, 36 and the number of viable cells was determined. Detailed procedures are presented in the ESI. † 2.7. Growth curve and 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay
To analyse the effect of the biolm inhibitory concentration of ADP (100 mg mL À1 ) on the growth of MRSA, the optical density was measured at 600 nm over a period of 24 h at 1 h intervals. In addition, the metabolic activity and viability of MRSA grown in the absence and presence of ADP (100 mg mL À1 ) were assessed using an XTT assay.
C. elegans maintenance and toxicity assay
Wild-type N2 Bristol C. elegans was obtained from the Caenorhabditis Genetics Center and maintained in nematode growth medium (NGM). 37 To study the effect of ADP on fat accumulation, wild-type N2 Bristol C. elegans was raised in NGM containing a normal diet (12.5 mM cholesterol), a high fat diet (25 mM cholesterol) and a high fat diet supplemented with 100 or 200 mg mL À1 of ADP with an E. coli OP50 lawn. To evaluate the combination of ADP and antibiotics on the survival of C. elegans upon MRSA infection, age-synchronized L4 stage animals (N ¼ 20) were transferred to a 24-well plate containing 1 mL of sterile M9 buffer supplemented with or without 100 mg mL À1 of ADP, 0.01 mg mL À1 of rifampicin or a combination of 100 mg mL À1 ADP + 0.01 mg mL À1 rifampicin. A threehour culture of MRSA was added (20% inoculum) to each well, and the plates were incubated at 20 C and examined for the survival of C. elegans. The worms were observed under an inverted microscope and the number of viable worms was counted every 24 h. The animals were considered to be dead if they did not respond to gentle tapping or touching with a platinum worm picker loop. C. elegans fed with E. coli OP50 (a laboratory food source) served as a control.
Quantitative real-time PCR analysis
Total RNA was extracted from control and 100 mg mL À1 ADPtreated MRSA using the Trizol method and converted into cDNA using a Superscript III kit (Invitrogen Inc., USA). Quantitative real-time PCR analysis (qPCR) was performed on an Applied Biosystems thermal cycler using the Power SYBR Green PCR Master Mix. The Ct value of gyrB (gyrase) in each sample was calculated using a relative relationship method supplied by the manufacturer (Applied Biosystems). Details of the qPCR thermal conditions and the primer sequences of the genes (agrA, agrC, sarA, sigB, saeS, icaA, icaD, fnbA, fnbB, clfA, cna, epbs, altA, sea, sspB, aur, hld, hla, geh and crtM) used in this study are given as ESI. †
Estimation of triglycerides
Control, high fat diet-fed and high fat diet supplemented with 100 or 200 mg mL À1 ADP-fed C. elegans were washed with M9 buffer and sonicated in triglyceride assay buffer. Aer sonication, the C. elegans lysates were centrifuged at 10 000 rpm for 10 min to collect the supernatants. The triacylglyceride content was measured using a BioVision triglyceride assay kit (Mountain view, CA, USA) as per the manufacturer's protocols. In addition, the protein content was also quantied using a Bradford assay kit (BioRad). elegans were ground with 150 mg of potassium bromide and dried under vacuum to prepare a pellet. Infrared spectra were then collected in the range of 400 to 4000 cm À1 using an FTIR spectrometer (Bruker Tensor 27) and the values were plotted as intensity against wavenumber. 40 
Pharyngeal pumping assay
To determine the pumping rate of the pharynx, control, high fat diet-fed and high fat diet supplemented with 100 or 200 mg mL À1 of ADP-fed C. elegans were placed on separate NGM plates seeded with OP50. Pharyngeal pumping was observed carefully for 10 s under a stereomicroscope. 41 
Food consumption assay
The effect of ADP treatment on food consumption was evaluated by incubating C. elegans in M9 buffer containing UV-killed E. coli OP50 (OD 600 ¼ 0.4) for 36 h at 20 C, and the OD of the M9 buffer was measured at different time intervals. A reduction in cell density was considered as active food consumption. 42 
Egg laying assay
Age-synchronized young adult worms were transferred to standard NGM containing E. coli OP50 lawns. The number of eggs laid and progenies produced by individual worms was counted for 6 days. 40 
Locomotion assay
The locomotion of control, high fat diet-fed and high fat diet supplemented with 100 or 200 mg mL À1 of ADP-fed C. elegans was quantied by counting the number of forward body bends per min under an inverted light microscope at 8Â magnication. 
Quantitative real-time PCR analysis
Total RNA was extracted from control, high fat diet-fed and high fat diet supplemented with 200 mg mL À1 of ADP-fed C. elegans using the Trizol method and converted into cDNA using a Superscript III kit (Invitrogen Inc., USA). Quantitative realtime PCR analysis (qPCR) was performed on an Applied Biosystems thermal cycler using the Power SYBR Green PCR Master Mix. The Ct value of the b-actin in each sample was calculated using a relative relationship method supplied by the manufacturer (Applied Biosystems). Details of the qPCR thermal conditions and the primer sequences of the genes (atgl-1, daf-2, daf-16, ins-7, sod, eat-2, skn-1, aak-1, akt-1, age-1, egl-8, sams-1, fat-5, sgk-1 and acs-1) used in this study are given as ESI. †
Molecular docking analysis
The crystal structures of dehydroxysqualene synthase CrtM (ID: 2ZCO) and stearoyl-coenzyme A desaturase-1 (ID: 4ZYO) were retrieved from the protein data bank. The modelled structures of delta(9)-fatty-acid desaturases such as fat-5 (ID: FAT6_-CAEEL), fat-6 (ID: FAT6_CAEEL) and fat-7 (ID: FAT6_CAEEL) were downloaded from the protein model portal and the chemical structure of ADP was downloaded from PubChem (CID: 54722209). Molecular docking was carried out using Glide version 5.5 (Schrödinger Inc., New York, USA). 45 
Statistical analysis
All the experiments were performed independently in triplicate. Data were analyzed by one-way analysis of variance (ANOVA), with a signicance p-value of 0.05, using the SPSS (Chicago, IL, USA) statistical soware package.
Results and discussion
3.1. Effect of ADP on initial attachment, biolm formation, autoaggregation, virulence factor production, blood survival and growth of MRSA Biolm formation has been identied as an indispensable virulence mechanism of S. aureus responsible for its pathophysiology, antibiotic resistance and survival under in vivo conditions. 1 MRSA biolms formed on indwelling medical devices are difficult to treat/remove. 46 Hence, inhibition of biolm formation has become an alternative therapeutic strategy to control infections caused by MRSA. Bioactive compounds with the ability to inhibit biolm formation and other virulence factors, such as hemolysin, lipase, autolysin, staphyloxanthin and hyaluronidase, could be useful in controlling infections caused by MRSA.
The ability of standard ADP to inhibit biolm formation by MRSA was assessed using a standard 24-well MTP assay coupled with CV staining (Fig. 1a) and spectrophotometric quantica-tion. The results revealed concentration-dependent inhibition of MRSA biolm formation. Notably, 50 and 90% biolm inhibition was observed at 50 and 100 mg mL À1 of ADP and these concentrations were denoted as the sub-BIC and BIC, respectively (Fig. 1b) . The biolm inhibition observed in the present study falls in line with the antibiolm activity shown by red wines 47 and coral-associated bacterial extracts 29 in terms of percentage of biolm reduction. In addition, ADP also exhibited dose-dependent inhibition of the initial adherence of MRSA to plastic surfaces (Fig. 1b) . A plasma coating on glass and plastic surfaces mimics the in vivo conditions and allows MRSA to form a robust biolm. 29 Hence, the ability of ADP to inhibit biolm formation on plasma-coated glass and polystyrene surfaces has been analysed. Spectrophotometric quantication revealed the ability of ADP to inhibit MRSA biolm formation on the plasmacoated polystyrene surface (Fig. 1b) . The antibiolm activity of ADP was further conrmed using light microscope and CLSM analysis. The light micrographs showed the reduction of biolm formation on both glass and plasma-coated glass surfaces (Fig. 1c) . CLSM analysis clearly showed a typical multi-layer of adherent cells with microcolony and macrocolony formation in the MRSA control. In contrast, the MRSA biolm formed in the presence of 50 and 100 mg mL À1 of ADP showed reduced formation of a multi-layer of adherent cells, as well as reduced surface colonization and thickness (Fig. 1d) . These results further conrm the potent antibiolm activity of ADP against MRSA. Similar to Gram-negative bacteria, MRSA also forms a ring biolm at the air-liquid interface. The results of the ring biolm assay clearly show the ability of ADP to inhibit biolm formation at the air-liquid interface (Fig. 1e) . Autoaggregation has been reported as an important event in biolm formation.
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Interestingly, addition of ADP to the growth medium reduced the autoaggregation of MRSA in a concentration-dependent manner (Fig. 1f) . The non-toxic nature of ADP and its ability to inhibit biolm formation and autoaggregation of MRSA is of great signicance for drug development. AIP-mediated signalling is present in a wide range of Grampositive pathogens.
49 Therefore, we have evaluated the effect of ADP on biolm formation by Staphylococcus epidermidis and Enterococcus faecalis. In addition, the antibiolm activity of ADP was evaluated against Gram-negative and Gram-positive pathogens such as Pseudomonas aeruginosa, Serratia marcescens, Vibrio harveyi, Vibrio parahaemolyticus, Vibrio alginolyticus, Escherichia coli, Proteus mirabilis, Proteus vulgaris, Klebsiella pneumoniae, Streptococcus mutans and Bacillus subtilis. The results revealed the absence of antibiolm activity at 1 mg mL À1 of ADP (Fig. 2) . Hence, we assume that the antibiolm activity of ADP against MRSA could be due to the modulation of specic mechanism(s).
Biolm inhibitors have been reported to inhibit slime synthesis in S. aureus. 29, 50, 51 Hence in the present study, the effect of ADP on slime production was assessed using a CRA plate assay. The results showed a reduction in the Bordeaux red colouration of the colonies and black colouration around them (Fig. 3a) . These results suggested that ADP was able to interfere with EPS production. A recent report stated that the reduction of slime synthesis by berberine is attributed to the inhibition of amyloid bril formation of MRSA. 50 In addition, colonies of MRSA on TSB agar without ADP were found to be smooth and mucoid, and exhibit a spreading pattern, whereas in the presence of ADP (100 mg mL À1 ) on TSB agar, MRSA formed rough and non-spreading colonies (Fig. 3b) . Autoaggregation and biolm formation of S. aureus requires autolysin-mediated eDNA release. Autolysin (AtlA) mutants have been reported to be defective in biolm formation 48 and hence the effect of ADP treatment on autolysin production in MRSA was assessed spectrophotometrically. The results showed the presence of active lysis in the control cells, whereas in the ADPtreated cells, a dose-dependent reduction in autolysis was observed in the presence of 0.02% Triton X-100 (Fig. 3c) . These results suggest that inhibition of autoaggregation and autolysin production by ADP could be one of the mechanisms responsible for the impairment of biolm formation.
Furthermore, the effect of ADP on lipase and protease production was also analysed. Lipase produced by S. aureus is responsible for accumulation of granulocytes and protects the cells from antimicrobial lipids secreted by the human skin. The results of the lipase assay showed that ADP was able to inhibit lipase production in a concentration-dependent manner (Fig. 3d) . In addition to biolm formation, S. aureus depends on an array of cytotoxins that assault the innate immune cells, and these cytotoxins have been shown to have a pivotal role in establishing infections under in vivo conditions. a-Hemolysin is one such important virulence factor produced by S. aureus involved in the necrosis of host cells that forms a b-barrel transmembrane aqueous channel with a diameter of 14 A to allow the transport of K + and Ca 2+ ions. Importantly, lymphocytes and monocytes are highly susceptible to a-hemolysin. 52 Hence, inhibition of hemolysin production in S. aureus is a plausible strategy to mitigate cellular damage during infection. The results of the hemolysin assay revealed a concentration-dependent reduction in hemolysin production upon ADP treatment. Briey, 50% and complete inhibition of hemolysin was observed at 30 and 70 mg mL À1 of ADP (Fig. 3d) . Hemolysin production is also related to biolm formation in S. aureus and hence the biolm inhibition by ADP may be attributed to its hemolysin inhibitory activity. Compounds like 1,3-benzodioxoles and benzo-1,4-dioxanes are found to inhibit autoinducing peptide (AIP)-regulated lipase and a-hemolysin production in S. aureus.
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Inhibition of lipase and hemolysin production by ADP suggests that it is able to interfere with AIP-mediated signalling in S. aureus.
S. aureus depends on the antioxidant potential of a carotenoid pigment called staphyloxanthin for its survival under adverse in vivo conditions and to escape from innate immune responses. 37 Inhibition of staphyloxanthin has been reported to increase neutrophil-mediated killing and affect the survival of S. aureus in the presence of oxidants. 35 Hence, the inhibition of staphyloxanthin pigment production is one of the therapeutic strategies to make S. aureus more susceptible to antibiotics and immune responses. Benzofuran derivatives, the cholesterol biosynthesis inhibitor phosphonosulfonate BPH-652 (ref. 23) and the human squalene synthase inhibitor zaragozic acid have been reported to have strong inhibitory activity against staphyloxanthin production in MRSA. ADP inhibited staphyloxanthin production in a concentration-dependent manner ( Fig. 4a and b) . In addition, the effect of ADP on staphyloxanthin production in MRSA was also assessed by measuring the amount of staphyloxanthin and its metabolic intermediates, including 4,4 0 -diapophytoene, 4,4 0 -diaponeurosporene and 4,4 0 -diaponeurosporenic acid, spectrophotometrically. The results revealed the concentration-dependent inhibitory activity of ADP against 4,4 0 -diapophytoene (Fig. 4c) , 4 0 -diaponeurosporene (Fig. 4d) , 4 0 -diaponeurosporenic acid (Fig. 4e ) and staphyloxanthin ( Fig. 4f ) production in MRSA. Since staphyloxanthin protects MRSA from oxidative stress and the host innate immune responses, 35 we also assessed the effect of ADP treatment on the survival of MRSA in whole blood, and the sensitivity of MRSA to H 2 O 2 and methylene blue. The results showed that the survival of MRSA control cells in whole blood did not change. In contrast, the ADP-treated MRSA cells were highly sensitive to whole blood (Fig. 4g) . As expected, the ADP-treated MRSA cells were highly susceptible to H 2 O 2 ( Fig. 4h ) and methylene blue (Fig. 4i ) in comparison to control cells. These results further conrmed the potential of ADP to inhibit staphyloxanthin pigment production and consequently the survival of MRSA in the presence of oxidants and neutrophils. The results observed in the present study correlate well with a previous report, in which rhodomyrtone was found to affect staphyloxanthin biosynthesis, the survival of MRSA in whole blood and the susceptibility of MRSA towards H 2 O 2 and methylene blue. 55 An ideal antibiolm/antipathogenic agent is expected to not have any negative inuence on the proliferation and basic metabolic activity of the pathogens. 56 Growth curve analysis was performed to study the effect of ADP (100 mg mL À1 ) on the growth of MRSA and the kinetic growth measurements suggested that ADP was non-bactericidal/bacteriostatic in nature (Fig. 4j) . In addition, an XTT assay also showed an insignicant difference in the metabolic activity of control MRSA and MRSA treated with different concentrations of ADP (Fig. 4k) .
Effect of a combination of ADP and antibiotics on the growth of MRSA
To evaluate the non-toxic nature of ADP, age-synchronized C. elegans N2 worms were treated with 200 to 1600 mg mL À1 of ADP throughout their lifespan. The toxicity of ADP was ruled out, as 800 mg mL À1 of ADP did not alter the lifespan of the C. elegans N2 ) on the biofilm formation of S. epidermidis (SE), E. faecalis (EF), S. mutans (SMT), B. subtilis (BS), P. aeruginosa (PA), S. marcescens (SM), V. harveyi (VH), V. parahaemolyticus (VP), V. alginolyticus (VA), E. coli (EC), P. mirabilis (PM), P. vulgaris (PVG) and K. pneumoniae (KP). Error bars indicate SDs from the mean (n ¼ 6 (biological triplicates in technical duplicates)). worms (Fig. 5a ). Anti-QS/antibiolm agents have been documented for their ability to enhance the antimicrobial potential of antibiotics. 57 For instance, hamamelitannin has been reported to increase the activity of antibiotics against MRSA. 58 Furthermore, certain bioactive compounds have very meagre/no antimicrobial activity against bacterial pathogens but enhance the activity of antibiotics and are active in blocking resistance when they are administered along with antibiotics. 59 Such compounds are called Class I adjuvants (beta-lactamase inhibitors, efflux inhibitors, biolm inhibitors and compounds enhancing the membrane permeability) and Class II adjuvants (compounds that enhance the antimicrobial activity by interacting with/activating the host immune response), and are collectively known as antibiotic adjuvants. 59 The sub-MICs of oxacillin (OXI), linezolid (LNZ), vancomycin (VAN) and rifampicin (RIF) were determined to be 128, 0.75, 0.125 and 0.01 mg mL
À1
, respectively. ADP was found to be inactive in terms of antibacterial activity against MRSA even at 15 mg mL
. Subsequently, the growth of MRSA in the presence of 100 mg mL À1 of ADP and a sub-MIC concentration of the selected antibiotics alone or in combination was measured spectrometrically. The results revealed that combinations of antibiotics with ADP were found to be more active in inhibiting the growth of MRSA than the sub-MICs of the antibiotics alone (Fig. 5b) . Recently, Trizna et al. have reported that treatment with furanones F35 and F83 effectively increased the susceptibility of S. aureus to chloramphenicol by attenuating biolm formation, while chloramphenicol alone was inactive. 60 Hence, the enhanced antibacterial activity of OXI, LNZ, VAN and RIF at their sub-MICs in the presence of ADP could be attributed to the inhibition of the production of a biolm, staphyloxanthin, slime and other virulence factors, and not to synergistic or additive activity. In addition, the efficacy of 100 mg mL À1 of ADP, a sub-MIC concentration (0.01 mg mL À1 ) of RIF and their combination on the survival of C. elegans during MRSA infection was analysed.
The combination of antibiotics with ADP was found to be active in rescuing C. elegans from MRSA infection (Fig. 5c) . These results further conrm the ability of ADP to enhance the activity of antibiotics in controlling the growth of MRSA. Hence, ADP can be used along with antibiotics to overcome infections caused by MRSA.
Effect of ADP on the expression of virulence and biolm genes in MRSA
The accessory gene regulator (agr) system is known to induce the expression of toxins and extracellular virulence factors through RNA III dependent and independent pathways. 61, 62 To study the effect of ADP on the agr system, the expression of the response regulator agrA and the transmembrane protein agrC was analysed. The results revealed the down-regulation of agrC upon ADP treatment, whereas the expression of agrA remained unaltered (Fig. 6) . Down-regulation of agrC is expected to have a negative impact on the activation of virulence genes.
Interestingly, the expression of sigB was found to be upregulated upon ADP treatment. SigB is a general stress response regulator known to regulate several cellular processes. 63 Mutation in sigB has been reported to induce the expression of virulence genes such as sea and seb (enterotoxin A & B), aur (aureolysin), spc (staphylokinase), geh (lipase), hla (alphahemolysin) and hlb (beta-hemolysin), and hence sigB has been shown to be a negative regulator of most exoenzymes and toxins. 64 Furthermore, sigB also promotes the survival of MRSA in the presence of blood, H 2 O 2 and UV by increasing the production of staphyloxanthin pigment.
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Hence, downregulation of virulence genes such as geh and sea upon ADP treatment could be attributed to the upregulation of sigB, which is known to be involved in disease progression. 66 These results suggest that ADP can interfere with the activation of virulence genes by modulating the expression of sigB.
The intracellular adhesion locus (icaABCD) has been shown to regulate cell-to-cell adhesion by controlling the synthesis of polysaccharides (PIA). 67 Gene expression analysis revealed that ADP treatment does not have any negative impact on the expression of icaA (N-acetyl glucosamine), whereas the expression of the icaD gene (encoding poly-beta-1,6-N-acetyl glucosamine biosynthesis protein) was down-regulated (Fig. 6) . It has been previously reported that icaA requires the action of icaD for optimal production of PIA.
68 Hence down-regulation of icaA by ADP could be one of the mechanisms involved in the reduced biolm formation of MRSA. SarA mutants have been reported to be defective in biolm formation. In addition, compounds targeting the expression of sarA have been shown to have potent antibiolm and antivirulence activity. 69 In contrast, ADP treatment enhanced the expression of sarA and sarA-controlled adhesion proteins fnbA and fnbB (bronectin binding proteins). A similar expression pattern was observed in a previous study, wherein magnolol treatment induced the expression of sarA in S. aureus. In addition, the dose-dependent autolysin inhibition by ADP observed in the present study agrees well with the autolysin inhibitory activity of magnolol as previously reported. 70 Real time PCR analysis of altA (autolysin) further conrms the autolysin inhibitory potential of ADP. In addition, the expression of cna (collagen binding protein), saes (histidine protein kinase), ebps (elastin binding protein) and clfA (clumping factor) was down-regulated upon ADP treatment (Fig. 6) . Down-regulation of these genes involved in biolm formation by ADP could be one of the mechanisms responsible for its antibiolm activity.
Since crtM is an important enzyme involved in the biosynthesis of staphyloxanthin, 18 down-regulation of crtM by ADP could be a possible mechanism responsible for staphyloxanthin inhibition. In addition, ADP does not alter the expression of proteases such as sspB (cysteine protease) or aur (Fig. 6) , which are known to be involved in biolm disruption. In contrast to the hemolysin assay, real-time PCR analysis showed the upregulation of hld, whereas the expression of hla remained unaltered upon ADP treatment (Fig. 6d) . Owing to the detergent like structure of ADP and the results observed in the gene expression analysis, we presume that the antibiolm activity of ADP could be multifaceted.
Effect of ADP on triacylglyceride accumulation, physiology and gene expression in C. elegans
Dehydrosqualene synthase (CrtM), a key enzyme involved in the initial steps of staphyloxanthin biosynthesis in MRSA, and human squalene synthase (SQS), involved in cholesterol biosynthesis in humans, were found to have similarity in their structures. The cholesterol biosynthesis inhibitor BPH-652 has been reported to have potent inhibitory activity against staphyloxanthin production. 23 In the present study, ADP inhibited staphyloxanthin production in MRSA. Hence, the effect of ADP on triglyceride accumulation was analysed using the nematode model C. elegans. Numerous studies have shown C. elegans to be one of the simplest models for studying fat metabolism and screening anti-obesity agents. 26 In C. elegans, excess energy is stored as triglycerides in the form of lipid droplets. C. elegans raised in high fat (25 mM cholesterol)-containing NGM was found to exhibit increased triglyceride levels. Anti-obesity agents such as taurine, 26 conjugated linoleic acid mixture,
71
Xenical® and Reductil® 72 have been found to reduce triglyceride accumulation in C. elegans. Furthermore, natural products such as hesperidin 43 and Pu-Erh tea 73 have been reported to mitigate triglyceride accumulation in C. elegans. To ascertain the effect of ADP treatment on triglyceride accumulation, C. elegans was raised with a high-fat diet (NGM containing 25 mM cholesterol), and the triglyceride content was measured. The results suggested that ADP treatment reduced triglyceride accumulation in C. elegans. Briey, feeding with a high-fat diet resulted in accumulation of $74 ng of triglyceride per worm; in contrast C. elegans fed a high fat diet containing 200 mg mL À1 of ADP exhibited reduced triglyceride accumulation ($51 ng per worm) (Fig. 7a) . In other words, the triglyceride content of ADPtreated C. elegans was found to be similar to that of C. elegans raised in normal NGM. In addition, the ability of ADP to inhibit triglyceride accumulation was further conrmed using Oil Red O and Sudan Black staining. Microscopic observation of worms stained with Oil Red O (Fig. 7c) and Sudan Black (Fig. 7d) showed a typical red and black coloured fat mass, respectively, in C. elegans. Comparison of the control, high fat diet-fed and ADP-treated C. elegans revealed the reduction of fat mass upon ADP treatment. FTIR has been used as a powerful tool to study biomolecular complexes. 74 In the present study, FTIR was used to further authenticate the effect of ADP treatment on the triacylglyceride accumulation in C. elegans. The results of the FTIR analysis showed prominent signature peaks at 3000-2800 cm À1 corresponding to fatty acids 75 for C. elegans raised in high fat dietcontaining NGM. Interestingly, peaks corresponding to fatty acids were not observed in C. elegans raised in standard NGM or NGM supplemented with a high fat diet and 200 mg mL À1 of ADP (Fig. 7e) . The FTIR data undisputedly conrmed the ability of ADP to inhibit the accumulation/synthesis of triglycerides in C. elegans. Pharyngeal pumping is considered to be a direct measure of active food consumption and neuronal signalling. 76 Hence, the effect of ADP treatment on pharyngeal pumping was monitored. The results did not show any signicant difference in the pharyngeal pumping of C. elegans raised with a normal diet, a high fat diet and a high fat diet supplemented with 100 or 200 mg mL À1 of ADP (Fig. 8a) . Dietary restriction has previously been reported to reduce the fat accumulation, brood size and longevity of C. elegans. 77, 78 Hence we analysed the inuence of ADP treatment on food consumption using a 24-well MTP plate assay by incubating C. elegans (N ¼ 50) raised in standard NGM, and high fat-containing NGM without and with 100 or 200 mg mL À1 of ADP in M9 buffer containing heat UV irradiated E. coli OP50 (OD 600 ¼ 0.4) as a food source, and there was no signi-cant difference in the reduction in cell density (Fig. 8b) . These results indicate that ADP did not have any negative impact on food consumption in C. elegans. In addition, the effect of ADP on the brood size of C. elegans was also analysed and the results revealed that there was no signicant difference in progeny production during the observed period (Fig. 8c) . Furthermore, the effect of ADP on the locomotion of C. elegans was assessed by measuring the body bend count per minute. There was no signicant difference in the mean body bend count of C. elegans (N ¼ 10) raised in standard NGM, and high fat-containing NGM without and with 100 or 200 mg mL À1 of ADP (Fig. 8d) . The results of the locomotion assay suggested that ADP did not have any modulatory effect on the cholinergic system of C. elegans. Interestingly, uorescence microscopic analysis of 2 0 ,7 0 -dichlorodihydrouorescein diacetate (H 2 DCFDA)-stained worms revealed a reduction in reactive oxygen species (ROS) generation in ADPtreated C. elegans as compared to high fat diet-fed C. elegans (Fig. 8e) . Inhibition of ROS generation suggested that ADP does not exert any oxidative stress on C. elegans.
In C. elegans, D9 desaturases/stearoyl-CoA desaturases such as fat-5, fat-6 and fat-7 are involved in the synthesis of oleic acid by converting palmitic acid to palmitoleic acid, and palmitoleic acid to stearic acid, followed by the conversion of stearic acid to oleic acid, respectively. 79 Loss of fat-6 leads to a reduction in long chain unsaturated fatty acids in C. elegans. 80 Interestingly, ADP downregulated the expression of fat-6 even in the presence of cholesterol (Fig. 8e) . Since, oleic acid is a primary substrate for the biosynthesis of triglycerides and other complex lipids, downregulation of fat-6 by ADP could be a possible mode of action responsible for the quelling of triacylglyceride accumulation in C. elegans. Fatty acid metabolism in C. elegans is also regulated by DAF-2/insulin like signalling (ILS), 81 and hence in the present study we have analysed the effect of ADP treatment on genes involved in the DAF-2/ILS pathway, such as ins-7 (insulin/IGF-1-like peptide), daf-2 (insulin/IGF receptor ortholog), daf-16 (forkhead box O (FOXO) homologue), age-1 (phosphoinositide 3-kinase), akt-1 (serine/threonine kinase), sgk-1 (serine/threonine protein kinase) and skn-1 (bZip transcription factor ortholog). The expression of daf-16 was upregulated and ins-7, age-1 and sgk-1 are found to be down-regulated upon ADP treatment (Fig. 8f) . It has been previously reported that the binding of ins-7 to daf-2 is necessary for the expression of age-1 and pdk-1 and the phosphorylation of akt-1/2 and sgk-1, which in turn phosphorylates daf-16. Phosphorylation of daf-16 blocks its nuclear translocation and reduces the lifespan of C. elegans.
82 Upregulation of daf-16 and down-regulation of ins-7 by ADP could be a possible mechanism responsible for the normal lifespan of C. elegans. Similar to daf-2 mutants, age-1 mutants have also been reported to exhibit an extended lifespan.
83 Down-regulation of age-1 and upregulation of sod (superoxide dismutase) by ADP (Fig. 8f) agrees well with a previous study, wherein age-1 mutants produced an increased level of antioxidant enzymes such as superoxide dismutase and catalase when compared to the parental strain. 84 Furthermore, sgk-1-mediated Rictor/TORC2 regulation is responsible for fat storage and development of C. elegans and the loss of sgk-1 leads to a reduction in fat storage and an increase in the level of reactive oxygen species (ROS). 85 Upregulation of sod by ADP could be the key mechanism responsible for the reduction of ROS accumulation in C. elegans as evidenced by uorescence microscopy analysis using DCFDA.
Furthermore, ADP treatment also down-regulated S-adenosylmethionine synthase (sams-1), which is a known methyl group donor in many biochemical reactions (Fig. 8f) . Knockdown of sams-1 has been reported to increase the lifespan of wild-type C. elegans. 86 Metformin, a biguanide drug, is used as an oral drug to control type 2 diabetes and its supplementation in NGM was found to cause dietary restriction by down regulating the expression of sams-1. 87 In contrast, ADP did not cause any effect similar to dietary restriction in C. elegans as evidenced by the food consumption and pharyngeal pumping assay. Furthermore, the expression of eat-2 (ligand-gated ion channel subunit) was found to be normal upon ADP treatment (Fig. 8f) and hence the reduction of fat accumulation could be due to inhibition of fatty acid biosynthesis and not dietary restriction. C. elegans depends on atgl-1 (adipose triglyceride lipase 1) for the generation of free fatty acids from stored fat droplets and maintains lipid homoeostasis. 88 The insignicant difference in the expression of atgl-1 in C. elegans raised with a high fat diet and a high fat diet supplemented with ADP indicated that the reduction in triglyceride accumulation is due to ADP treatment and not due to the expression of atgl-1. In addition, ADP does not have any impact on the expression of egl-8, responsible for egg laying (Fig. 8f) .
Molecular docking analysis
Structure-based virtual screening methods have successfully been employed for the identication and design of a wide range of pharmacologically active compounds against drug targets. In addition, in silico approaches are also used to predict the interaction of known druggable target proteins and their native ligands/drugs. 27, 45 The precursor molecules of staphyloxanthin biosynthesis and triglyceride biosynthesis in C. elegans, such as 2Â farnesyl diphosphate 23 and palmitoleic acid, 79 respectively, share structural similarity with ADP and hence ADP could act as a competitive inhibitor. Hence, in the present study, ADP was docked with CrtM (involved in the rst step of staphyloxanthin biosynthesis of MRSA) and fat-5, fat-6 and fat-7 (involved in the oleic acid biosynthesis of C. elegans) to probe their interaction. Furthermore, human stearoyl-coenzyme A desaturase-1 (SCD1) has been proven as a druggable target to design therapeutic agents to treat metabolic diseases, and hence SDC1 was also included in the molecular docking study. The results of the molecular docking studies predicted the ability of ADP to interact with all of the selected target proteins. Briey, ADP interacts with the active sites of fat-5, fat-6 and fat-7 through 3 hydrogen bonding interactions (Val 155, Asn 116 and Lys 156) (Fig. 9a) , 2 hydrogen bonding interactions (Asn 125 and Arg 50) (Fig. 9b ) and one hydrogen bonding interaction (Arg 49) (Fig. 9c) , respectively. In the case of CrtM, ADP interacts through 3 hydrogen bonding interactions (Arg 45, Asp 48 and Tyr 183) (Fig. 9d) . ADP also interacts with human SDC1, which is involved in fatty acid metabolism, through 2 hydrogen bonding interactions (Asn 75 and Arg 188) and a salt bridge interaction (Arg 74) (Fig. 9e) . These results imply that the binding of ADP to the active sites of target enzymes involved in oleic acid production could be a possible mechanism responsible for the reduction of triglyceride accumulation in C. elegans.
Treatment of S. aureus with rhodomyrtone has been reported to inhibit staphyloxanthin production by down-regulating the expression of sigB. However, in the present study, ADP treatment was found to upregulate sigB expression and we speculate that the inhibition of staphyloxanthin production could be due to a sigB-independent mechanism. Based on the molecular docking analysis and the structural similarity of 2Â farnesyl diphosphate with ADP, it is hypothesized that the interaction of ADP with CrtM, as well as down-regulation of crtM, could be a plausible mechanism responsible for staphyloxanthin biosynthesis in MRSA.
Conclusion
The current study reveals that ADP has antibiolm, antipathogenic and anticarotenogenic potential. ADP inhibited biolm, lipase, hemolysin, and protease production in a concentration-dependent manner. qPCR analysis revealed the differential expression of genes involved in biolm formation and virulence factor production in MRSA upon ADP treatment. In addition, ADP profoundly inhibited the carotenoid pigment staphyloxanthin, and hence its effect on triacylglyceride accumulation in C. elegans was also assessed. Interestingly, ADP was found to reduce triacylglyceride accumulation in C. elegans without exerting any negative impact on lifespan, food consumption, brood size etc. Microscopic observation of Oil Red and Sudan Black stained C. elegans raised with a normal diet, high fat diet and high fat diet supplemented with ADP showed the reduction of triacylglyceride accumulation. qPCR analysis revealed the differential expression of genes involved in fatty acid synthesis, insulin signalling and stress response. Furthermore, molecular docking analysis predicted the ability of ADP to bind with the active sites of CrtM in MRSA, and fat-5, fat-6 and fat-7 in C. elegans involved in staphyloxanthin and oleic acid biosynthesis, respectively. Owing to its non-toxic nature, antibiolm and antivirulence potential against MRSA, and triacylglyceride inhibitory activity in C. elegans, ADP holds promise for application in the eld of medical microbiology and metabolic syndrome therapeutics.
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